Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

Withdrawal symptoms can vary depending on the antidepressant, and strategies for tapering off the medication may help.

Coming off SSRIs can indeed be difficult, causing “SSRI discontinuation syndrome” in some people. The syndrome is characterised by flu-like symptoms, including dizziness, nausea, headaches and ...

Coming off SSRIs can indeed be difficult, causing “SSRI discontinuation syndrome” in some people. The syndrome is characterised by flu-like symptoms, including dizziness, nausea, headaches and ...

Researchers determined discontinuing BTK inhibitors appears to be more common than discontinuing venetoclax plus obinutuzumab for older patients with CLL.

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Wegovy and Ozempic have the same active ingredient, semaglutide. “Technically, they are exactly the same,” Dr. Maria Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinic’s ...